Story
Evidence, such as an email chain, video interview or other documentation, demonstrating collusion between Sanofi, Eli Lilly, and/or Novo Nordisk regarding their pricing for insulin. Documentation needs to demonstrate proof these companies knowingly engaged in raising prices together and engaged in anti-competitive trade practices. This could include a pharmaceutical benefits manager directly involved in price fixing such as CVS, Caremark, OptumRx, and/or Express Scripts.